Poongjeon Pharmacy CO.,LTD. (KOSDAQ: A298060)
Health Care · Biotechnology · KR
₩2,510.00
-3.65% today · -51.0% 1Y
Poongjeon Pharmacy CO.,LTD. (KOSDAQ: A298060) operates in the Biotechnology industry within the Health Care sector. The company is valued at $16.01M.
Over the last twelve months the share price has lost 51.0%, trading between 2.30K and 6.90K.
Tweenvest scores Poongjeon Pharmacy CO.,LTD. across four factors: quality 28/100, value 41/100, growth 100/100. Its strongest factor is growth.
A298060 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $16.01M
- Revenue (TTM)
- $1.14M
- P/E
- —
- EPS
- -362.75
- Dividend yield
- —
- Beta (5Y)
- 0.56
- 52-week high
- ₩6,900.00
- 52-week low
- ₩2,300.00
- Avg volume (3M)
- —
- Shares outstanding
- 8.84M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $467.44B | $265.79 | +0.48% |
| Amgen Inc.NasdaqGS: AMGN | $239.95B | $442.24 | -0.36% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.95B | $148.77 | +1.38% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.79B | $552.85 | +0.96% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $82.73B | $833.56 | +0.61% |
| argenx SEENXTBR: ARGX | $63.06B | €879.20 | +1.74% |
| CSL LimitedASX: CSL | $57.94B | AU$169.11 | +0.48% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $158.83 | +14.36% |
Figures last refreshed Aug 18, 2026.